Not applicableStudy completedNCT02969109
What this trial is testing
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
Who this might be right for
Non-muscle Invasive Bladder Cancer
Genomic Health®, Inc. 417